NYSE: VETVermilion Energy Inc Stock
$8.24+0.32 (+4.04%)
Updated Jun 13, 2025
VET Price
$8.24
Fair Value Price
N/A
Market Cap
$1.27B
52 Week Low
$5.14
52 Week High
$11.52
P/E
-54.21x
P/B
0.61x
P/S
0.93x
PEG
N/A
Dividend Yield
2.91%
Revenue
$1.40B
Earnings
-$23.67M
Gross Margin
61.8%
Operating Margin
3.37%
Profit Margin
-1.8%
Debt to Equity
1.46
Operating Cash Flow
$621M
Beta
1.28
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
VET Overview
Vermilion Energy Incorporated is a petroleum and natural gas exploration and development company. It owns an 81% working interest in 636,714 acres of developed land and an 85% working interest in 301,026 acres of undeveloped land in Canada, and 130,715 net acres of land in the Powder River basin in the U.S. It also owns s 20% interest in the Corrib natural gas field located off the shore of Ireland. Vermilion Energy was founded in 1994 and is headquartered in Calgary, Alberta.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine VET's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Oil and Gas
Industry Rating
D
VET
Ranked#54 of 75
Ranked#54 of 75
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $8.14 | B | |
| $5.98 | B | |
| $7.33 | B |
Be the first to know about important VET news, forecast changes, insider trades & much more!
VET News
Overview
Due Diligence Score
–
Industry Average (29)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how VET scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
VET is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
VET is good value based on its book value relative to its share price (0.61x), compared to the US Oil & Gas E&P industry average (1.65x)
P/B vs Industry Valuation
VET is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 35 more VET due diligence checks available for Premium users.
Valuation
VET price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-54.21x
Industry
17.08x
Market
31.36x
VET price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.61x
Industry
1.65x
VET is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
VET's financial health
Profit margin
Revenue
$372.1M
Net Income
$10.4M
Profit Margin
2.8%
VET's Earnings (EBIT) of $47.28M... subscribe to Premium to read more.
Interest Coverage Financials
VET's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$4.9B
Liabilities
$2.9B
Debt to equity
1.46
VET's short-term liabilities ($520.39M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
VET's long-term liabilities ($2.52B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
VET's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
VET's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$194.7M
Investing
-$872.0M
Financing
$601.4M
VET's operating cash flow ($647.71M)... subscribe to Premium to read more.
Debt Coverage Financials
VET vs Oil and Gas Stocks
Vermilion Energy Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.